Estrogen plus progestin increased risk for stroke and probable dementia in postmenopausal women

November 2003
ACP Journal Club;Nov/Dec2003, Vol. 139 Issue 3, p62
Academic Journal
This article cites a study regarding whether hormone replacement therapy (HRT) increases the risk of stroke in postmenopausal women. The incidence of ischemic and hemorrhagic strokes combined and of ischemic stroke alone were greater in the HRT group than in the placebo group. The groups did not differ for incidence of hemorrhagic stroke. The results were also not influenced by previous HRT use or timing of previous HRT initiation with respect to the final menstrual period.


Related Articles

  • Postmenopausal Hormone Therapy--the Final Word...Maybe.  // HealthFacts;Jun2003, Vol. 28 Issue 6, p6 

    Focuses on the Women's Health Initiative estrogen/progestin combination trial. Number of women who participated in the trial; Decline in cognitive functioning among women taking combination hormones; Risk of stroke.

  • Estrogen plus progestin increased risk for stroke and probable dementia in postmenopausal women: COMMENTARY. Atkins, David // ACP Journal Club;Nov/Dec2003, Vol. 139 Issue 3, p63 

    Most observational studies have reported substantially lower risk for dementia among women who had used hormone replacement therapy (HRT). The expectations of a protective effect against dementia were based on a compelling combination of basic science and epidemiology. In animal studies,...

  • Hormone Therapy and Increased Risk of Stroke. Wellbery, Caroline // American Family Physician;1/1/2004, Vol. 69 Issue 1, p204 

    Examines the effects of estrogen plus progestin on stroke in postmenopausal women. Health risks of the hormone therapy; Study population; Adverse effects of hormones across all age groups.

  • HRT increases risk of dementia and stroke.  // Contemporary OB/GYN;Jul2003, Vol. 48 Issue 7, p16 

    Reports on studies of the effect of postmenopausal hormone therapy (HRT) on the risk of dementia and stroke. Incidence of dementia in women taking estrogen plus progestin; Cognitive function of women receiving the estrogen/progestin treatment; Percentage increase in the risk of stroke among...

  • Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.  // Current Medical Literature: Stroke Review;2003, Vol. 7 Issue 3, p85 

    Reports on additional analyses from the Women's Health Initiative (WHI) trial of estrogen plus progestin on stroke in postmenopausal women. Goal of assessing the effect of estrogen plus progestin on ischemic and hemorrhagic stroke; Indication that conjugated equine estrogen plus...

  • Postmenopausal Hormone Therapy and Stroke. Speroff, Leon // OB/GYN Clinical Alert;Aug2008, Vol. 25 Issue 4, p25 

    The article discusses a study which examines the vital role of estrogen doses to the increased risk of stroke associated with hormone therapy. The study found that the risks associated with estrogen alone were statistically significant for near and far initiation than estrogen-progestin. The...

  • The Women's Health Initiative and HRT: Putting it all in perspective. Ravnikar, Veronica; Colodny, Charles; Judelson, Debra R.; Naftolin, Frederick; Santoro, Nanette // Patient Care for the Nurse Practitioner;Dec2002, Vol. 5 Issue 12, p3 

    This article discusses the Women's Health Initiative study of hormone replacement therapy (HRT). An arm of HRT was discontinued when an independent board found that risks of combined estrogen and progestin outweighed the benefits. Veronica Ravnikar, chair of the department of obstetrics and...

  • HRT: WHI results strike another blow.  // PharmaWatch: Cancer;April 2003, Vol. 2 Issue 4, p20 

    Reports on the analysis of data from the Women's Health Initiative study showing that women using estrogen-progestin hormone replacement therapy (HRT) experienced more strokes. Presentation of the results at the International Stroke Conference of the American Heart Association; Assessment of the...

  • Estrogen Replacement Therapy May Increase Risk of Dementia. Karlin, Susan // Discover;Jan2005, Vol. 26 Issue 1, p57 

    Suggests that consumption of estrogen-progestin combination may increase the risk of stroke, breast cancer and dementia, according to a series of studies funded by the National Institutes of Health in 2004. Highlights of the findings from the Women's Health Initiative Memory Study in June;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics